The Clinical Trials Transformation Initiative (CTTI) released new recommendations for enhancing the efficiency of clinical trial recruitment.
The Clinical Trials Transformation Initiative (CTTI) released new recommendations for enhancing the efficiency of clinical trial recruitment, and suggests starting the recruitment process earlier and being more inclusive of relevant stakeholders. CTTI’s recommendations are intended to dovetail with both its previously released Recommendations and Tools for Effective Engagement with Patient Groups Around Clinical Trials (PGCT) and Quality by Design Principles, Recommendations, and Toolkit (QbD).
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.